To highlight a rare case of perifoveal exudative vascular anomalous complex (PEVAC) with secondary fundus hemorrhage, emphasizing its clinical significance.
Key Findings:
PEVAC can lead to rupture and hemorrhage of secondary lesions, necessitating prompt intervention.
Intravitreal anti-VEGF treatment resulted in significant visual acuity improvement, highlighting its effectiveness.
The menstrual cycle may influence disease progression, though the relationship is unclear and warrants further investigation.
Interpretation:
The case illustrates the potential complications of PEVAC and the effectiveness of anti-VEGF therapy in managing visual impairment, suggesting a need for awareness among clinicians.
Limitations:
The relationship between the menstrual cycle and disease progression remains unclear, indicating a gap in understanding.
The study is based on a single case report, limiting generalizability and highlighting the need for larger studies.
Conclusion:
The case emphasizes the need for awareness of PEVAC and its complications, as well as the potential role of hormonal factors in disease progression, advocating for further research.
